quantified using ImageJ software. (mean ± s.e.m., n=4 independent experiments).(c) The proliferation of fibroblasts was determined as by BrdU incorporation assay (mean ± s.e.m., n=4 independent experiments).(d) Estimated copy numbers of miRNAs per macrophages. Equivalent molecules per cell were calculated based on the assumption that total RNA per cell is 20 pg. Black dots, blue ones and green ones indicate average molecules per macrophages treated by PBS, respectively (n=4) . (e) Macrophages were treated with IL-4 for 2 days. Afterward, the media were replaced and macrophages were treated with (IL4 for 7d) or without IL-4 (IL4 for 2d) for another 5 days. The expression of miR-142-5p and miR-130a-3p were examined by qRT-PCR at the indicated time points (mean ± s.e.m., n=3 independent experiments; *, p<0.05; **, p<0.01, ***, p<0.001 compared to control cells by two-tailed Student's t-tests)
Supplementary Figure 2. miR-142-5p and 130a-3p control M2 polarization(a)
Macrophages were transduced with indicated oligonucleotides using lentiviral vectors. After 24 hr, the cells were treated with IL-4 or IL-13 for 48 hr. CCL18 levels in the media were measured by ELISA (mean ± s.e.m, n=3 independent experiments; *, p<0.05; **, p<0.01 vs. IL-4/IL-13 activated macrophages transduced with control oligonucleotides. p values were obtained using two-tailed Student's t-tests).(b) Macrophages were transduced with negative control (nc) or miR-142-5p ASO or miR-130a-3p mimics or both using lentiviral vectors. After 24 hr, the cells were treated with IL-4 for 24 hr. The expression of miR-142-5p and miR-130a-3p of indicated cells were measured by Northern blot (left panels) and qRT-PCR (right panels, n=3).(c) Percentages of CD206 or CD36 positive macrophages treated as in Fig. 2b were determined as by flow-cytometry analysis. (mean ± s.e.m., n=4 independent experiments; ***, p<0.001 compared to control cells. #, p<0.05; ##, p<0.01; ###, p<0.001 compared to macrophages treated with IL-4 alone. p values were obtained using two-tailed Student's t-test).(d) Percentages of fibronectin positive macrophages treated as in Fig. 2c were quantitated by Image J (mean ± s.e.m, n=3 independent experiments; *, p<0.05; **, p<0.01; ***, p<0.001. p values were obtained using two-tailed Student's t-test).(e) Macrophages were transduced with negative control (nc) or miR-142-5p ASO or miR-130a-3p mimics or both using lentiviral vectors. After 24 hr, the cells were treated with IL-4 for 48 hr and pulsed with 1 mg ml -1 HRP for 2 hr. Measurements are expressed as the mean percentage of HRP uptake in untreated controls (mean ± s.e.m., n=4 independent experiments; *, p<0.05; ***, p<0.001. p values were obtained using two-tailed Student's t-test).(f) Macrophages were transduced with negative control (nc) or miR-142-5p ASO or miR-130a-3p mimics or both using lentiviral vectors. After 24 hr, the cells were treated with IL-13 for 48 hr. Cytokine levels in the media of macrophages were measured by ELISA (mean ± s.e.m., n=4 independent experiments; *, p<0.05; **, p<0.01; ***, p<0.001. p values were obtained using a two-tailed Student's t test).
Supplementary Figure 3 . miR-142-5p and 130a-3p regulate Mφ profibrogenesis (a-d) Macrophages were transduced with control or miR-142-5p ASO or miR-130a-3p mimics or both. After 24 hr, the macrophages were stimulated with IL-13 for 12 hr and co-cultured with primary human fibroblasts for another 48 hr.(a) Representative images of western blot for α-SMA and collagen III in fibroblasts. The numbers above the blots present the intensity ratio of indicated protein/GAPDH analyzed by ImageJ (n=2).(b) Extracellular acid-soluble collagen production of fibroblasts was measured by the Sircol assay. (mean ± s.e.m., n=4 independent experiments; **, p<0.01; ***, p<0.001. p values were obtained using two-tailed Student's t-test).(c) Fibroblast contractility in three-dimensional collagen matrix (mean ± s.e.m., n=4 independent experiments; *, p<0.01; **, p<0.001. p values were obtained using two-tailed Student's t-tests Supplementary Figure 5 . IL-4 downregulates miR-130a-3p by histone deacetylation (a) MM6 cells were transiently transfected with whole length or several deletion miR130a-luc constructs and pRL-TK-Renilla and harvested for the luciferase activity assay (mean ± s.e.m., n=3 independent experiments; **, p<0.01 using two-tailed Student's t-tests)(b) MM6 cells were transfected with a full-length or mutated reporter construct of miR130a and then exposed to DMSO or Sp1 inhibitors (mithramycin, mithr or WP631). Cells were harvested for the luciferase activity assay(mean ± s.e.m., n=3 independent experiments; **, p<0.01 using two-tailed Student's t-tests)(c) Primary human macrophages were incubated with or without IL-4 or LPS for 30 mins, Sp1 accumulations in cytoplasm and nucleus were determined by immunoblotting (n=2). The numbers above the blots present the intensity ratio of Sp1/GAPDH or laminB analyzed by ImageJ.(d) Schematic representation of the promoter region of miR-130a. CpG sites are shown as vertical bars.(e) Macrophages were stimulated with 20ng ml -1 IL-4 with or without pretreatment of DMSO or 5-Aza-dC (Aza).miR-130a expression was determined by qRT-PCR 24 hr afterward (mean ± s.e.m., n=3 independent experiments; **, p<0.01; n.s. not significant using two-tailed Student's t-tests 
